BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 34840325)

  • 1. Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Zou X; Xue M; Li J
    Med Sci Monit; 2021 Nov; 27():e934436. PubMed ID: 34840325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt.
    Lu HL; Xuan FF; Luo YC; Qin X
    Abdom Radiol (NY); 2021 Nov; 46(11):5417-5427. PubMed ID: 34302511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
    Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
    Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of variceal rebleeding and treatment of liver carcinoma by consecutive transjugular intrahepatic portosystemic shunt and hepatic artery chemoembolization.
    Nicolini A; Saccheri S; Lovaria A; Maggi A; Cazzaniga M; Panzeri A; Salerno F
    Ital J Gastroenterol; 1996 Jun; 28(5):269-71. PubMed ID: 8842845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.
    Leng X; Zhang F; Zhang M; Guo H; Yin X; Xiao J; Wang Y; Zou X; Zhuge Y
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):853-858. PubMed ID: 30633039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
    Chen Y; Ma X; Zhang X; Luo J; An L; Zhang Y; Chang X; Dong Z; Zhang W; Kong H; Zhao J; Ding H; Liu F; Yang Y
    Hepatol Int; 2022 Dec; 16(6):1379-1389. PubMed ID: 36255564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.
    Bettinger D; Knüppel E; Euringer W; Spangenberg HC; Rössle M; Thimme R; Schultheiß M
    Aliment Pharmacol Ther; 2015 Jan; 41(1):126-36. PubMed ID: 25329493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma.
    Balducci D; Montori M; De Blasio F; Di Bucchianico A; Argenziano ME; Baroni GS; Scarpellini E
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Transjugular Intrahepatic Portosystemic Shunt and Gastric Coronary Vein Embolization for Variceal Bleeding in Cirrhotic Portal Hypertension.
    Mukhiya G; Han X; Jiao D; Bi Y; Pokhrel G; Liu Z; Li Z; He Y
    Clin Med Res; 2023 Sep; 21(3):144-154. PubMed ID: 37985166
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Obliteration versus Transjugular Intrahepatic Portosystemic Shunt Alone for the Management of Gastric Varices: Comparative Single-Center Clinical Outcomes.
    Shah KY; Ren A; Simpson RO; Kloster ML; Mikolajczyk A; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
    J Vasc Interv Radiol; 2021 Feb; 32(2):282-291.e1. PubMed ID: 33485506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
    Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
    J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
    [No Abstract]   [Full Text] [Related]  

  • 14. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Qiu B; Li K; Dong X; Liu FQ
    Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1372-1382. PubMed ID: 28488102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.
    Hung ML; Lee EW
    Clin Liver Dis; 2019 Nov; 23(4):737-754. PubMed ID: 31563220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review.
    Norero B; Bosch J; Berzigotti A; Rodrigues SG
    United European Gastroenterol J; 2023 Oct; 11(8):733-744. PubMed ID: 37736854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization.
    Schultheiß M; Giesler M; Maruschke L; Schmidt A; Sturm L; Thimme R; Rössle M; Bettinger D
    Cardiovasc Intervent Radiol; 2019 May; 42(5):729-736. PubMed ID: 30788517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of concomitant variceal embolization and prophylactic antiplatelet/anticoagulative in transjugular intrahepatic portosystemic shunting: A retrospective study of 182 cirrhotic portal hypertension patients.
    Tang Y; Zheng S; Yang J; Bao W; Yang L; Li Y; Xu Y; Yang J; Tong Y; Gao J; Tang C
    Medicine (Baltimore); 2017 Dec; 96(49):e8678. PubMed ID: 29245228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt (TIPS) versus laparoscopic splenectomy (LS) plus preoperative endoscopic varices ligation (EVL) in the treatment of recurrent variceal bleeding.
    Zhou J; Wu Z; Wu J; Wang X; Li Y; Wang M; Yang Z; Peng B; Zhou Z
    Surg Endosc; 2013 Aug; 27(8):2712-20. PubMed ID: 23392981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.